EUVIMEDEUVIMED entdecken
Crossref

The clathrin adaptor AP1-S1 is associated with immune infiltration and HLA loss, as a potential therapeutic target in lung adenocarcinoma

Yafei Liu, Feng Li, Bin Wu, Lan Huang, Yu Qi

International Immunopharmacology · 2025-04 · 152 · 114385

DOI: 10.1016/j.intimp.2025.114385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Yafei Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Adaptor Protein Complex 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Henan Provincial Science and Technology Research Project, Health Commission of Henan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clathrin adaptor protein 1 (AP1) plays a pivotal role in the endocytosis of cell surface proteins and transportation between the golgi apparatus and lysosomes. Despite its critical functions, the implications of AP1 dysregulation in human cancers have yet to be elucidated. The structural analysis of AP1 subunits was conducted utilizing data from the Protein Data Bank (PDB), which is composed of four subunits: AP1-S1, AP1-B1, AP1-G1, and AP1-M1. Notably, the expression levels of AP1 subunits exhibit significant variability between tumor and normal tissues across different cancer types using data from the CPTAC, GEO, and TCGA databases. Kaplan-Meier (K-M) curve analysis has revealed that certain AP1 subunits are correlated with patient prognosis in various cancers. For instance, the AP1-S1 subunit is related to poor survival outcomes in head and neck squamous carcinoma, clear cell renal cell carcinoma, and lung adenocarcinoma. Furthermore, the aberrant expression of AP1-S1 demonstrated a negative correlation with immune cells infiltration, particularly in lung adenocarcinoma. Concurrently, a significant negative relationship between AP1-S1 and HLA molecules was observed, indicating a potential mechanism for AP1-induced HLA degradation. In vitro experiments demonstrated that the knockdown of AP1-S1 led to an upregulation of HLA-B protein expression and inhibited the viability, migration, and invasion capabilities of tumor cells in lung adenocarcinoma cell lines, specifically A549 and H1299. Immunohistochemical staining further revealed the abnormal expression of AP1-S1 in lung adenocarcinoma specimens. Through a comprehensive pan-cancer multi-omics analysis and experimental validation, this study explored the prognostic significance of four AP1 subunits. Additionally, it examined the regulatory relationship between AP1-S1 and HLA-B, which may play a role in immune escape. Additionally, the research identified AP1-S1 as a valuable biomarker and a potential target for treatment of lung adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungAdaptor Protein Complex 1HumansCell Line, TumorPrognosisGene Expression Regulation, NeoplasticCell Movement

Stichwörter der Autor:innen

AP1-B1AP1-G1AP1-M1AP1-S1HLA-lossImmunological regulationPrognosis

Substanzen

Adaptor Protein Complex 1

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: lanhuang@zzu.edu.cn.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: qiyu@zzu.edu.cn.

Förderung

  • Henan Provincial Science and Technology Research Project
  • Health Commission of Henan Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Li, F., Wu, B., Huang, L., & Qi, Y. (2025). The clathrin adaptor AP1-S1 is associated with immune infiltration and HLA loss, as a potential therapeutic target in lung adenocarcinoma. International Immunopharmacology, 152, 114385. https://doi.org/10.1016/j.intimp.2025.114385

Vancouver

Liu Y, Li F, Wu B, Huang L, Qi Y. The clathrin adaptor AP1-S1 is associated with immune infiltration and HLA loss, as a potential therapeutic target in lung adenocarcinoma. International Immunopharmacology. 2025;152:114385. doi:10.1016/j.intimp.2025.114385

BibTeX
@article{Liu2025,
  author = {Liu, Yafei and Li, Feng and Wu, Bin and Huang, Lan and Qi, Yu},
  title = {The clathrin adaptor AP1-S1 is associated with immune infiltration and HLA loss, as a potential therapeutic target in lung adenocarcinoma},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {152},
  pages = {114385},
  doi = {10.1016/j.intimp.2025.114385}
}
Kostenlos starten →